urea has been researched along with Migraine Disorders in 23 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| " For hemicrania we used cinnarizine, cyproheptadine, clonidine, histamine, pizotifene and reserpine; for cluster headache, cinnarizine, cyproheptadine, clonidine, histamine and reserpine; for tension headache, cyproheptadine; for psychogenic headache, allylpropylmalonylurea." | 5.04 | [Therapeutic possibilities in idiopathic headaches. Analysis of 1000 cases (author's transl)]. ( Agostoni, A; Brandi, G; Cottino, A; Gai, V; Gastaldi, L; Lisino, F; Nattero, G, 1975) |
| " The global incidence of adverse events was 45% higher with EC, though not significant (32 vs." | 2.69 | Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks. ( Geraud, G; Gómez, JP; Henry, P; Joffroy, A; Lainez, JM; Le Jeunne, C; Liaño, H; Pradalier, A; Titus i Albareda, F, 1999) |
| " By measuring the brain function using computer period analysis of cerebral biopotentials, dose-efficacy relations were found (in the range of 25-75 mcg) which suggest the bioavailability of LHM at the CNS level." | 2.64 | Prediction of psychotropic properties of lisuride hydrogen maleate by quantitative pharmaco-electroencephalogram. ( Akpinar, S; Herrmann, WM; Itil, TM, 1975) |
| "A rat model of migraine induced by recurrent administration of nitroglycerin (NTG) (5 mg/kg/i." | 1.62 | The involvement of orexin 1 and cannabinoid 1 receptors within the ventrolateral periaqueductal gray matter in the modulation of migraine-induced anxiety and social behavior deficits of rats. ( Abbasnejad, M; Esmaeili-Mahani, S; Kooshki, R; Pourrahimi, AM; Raoof, M, 2021) |
| "The NTG-induced migraine symptoms were recorded for 90 min." | 1.62 | Orexin one receptors within the basolateral amygdala are involved in the modulation of cognitive deficits associated with a migraine-like state in rats. ( Abbasnejad, M; Askari-Zahabi, K; Esmaeili-Mahani, S; Kooshki, R, 2021) |
| "To model chronic migraine-associated pain, nitroglycerin (NTG) (5 mg/kg/IP) was administered to test subjects every second day for 9 days." | 1.56 | Activation orexin 1 receptors in the ventrolateral periaqueductal gray matter attenuate nitroglycerin-induced migraine attacks and calcitonin gene related peptide up-regulation in trigeminal nucleus caudalis of rats. ( Abbasnejad, M; Esmaeili-Mahani, S; Kooshki, R; Raoof, M; Sheibani, V, 2020) |
| "This sensitisation reached a maximum in 60-90 min, at which time responses had risen to approximately twice that of control levels seen before the application of inflammatory soup." | 1.35 | The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission. ( Appleby, JM; Chizh, BA; Davis, JB; Hoskin, KL; Lambert, GA; Zagami, AS, 2009) |
| " The therapeutic cycles were standardized, for each drug, in the way of administration, dosage and total duration of the treatment." | 1.26 | [Therapeutic possibilities in idiopathic headaches. Analysis of about 1000 cases]. ( Agostoni, A; Brandi, G; Cottino, A; Gai, V; Gastaldi, L; Lisino, F; Nattero, G, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (73.91) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 1 (4.35) | 29.6817 |
| 2010's | 1 (4.35) | 24.3611 |
| 2020's | 3 (13.04) | 2.80 |
| Authors | Studies |
|---|---|
| Pourrahimi, AM | 1 |
| Abbasnejad, M | 3 |
| Raoof, M | 2 |
| Esmaeili-Mahani, S | 3 |
| Kooshki, R | 3 |
| Sheibani, V | 1 |
| Askari-Zahabi, K | 1 |
| Joshi, P | 1 |
| Anderson, C | 1 |
| Binch, H | 1 |
| Hadida, S | 1 |
| Yoo, S | 1 |
| Bergeron, D | 1 |
| Decker, C | 1 |
| terHaar, E | 1 |
| Moore, J | 1 |
| Garcia-Guzman, M | 1 |
| Termin, A | 1 |
| Lambert, GA | 1 |
| Davis, JB | 1 |
| Appleby, JM | 1 |
| Chizh, BA | 1 |
| Hoskin, KL | 1 |
| Zagami, AS | 1 |
| MEAD, BJ | 1 |
| Le Jeunne, C | 1 |
| Gómez, JP | 1 |
| Pradalier, A | 1 |
| Titus i Albareda, F | 1 |
| Joffroy, A | 1 |
| Liaño, H | 1 |
| Henry, P | 1 |
| Lainez, JM | 1 |
| Geraud, G | 1 |
| Herrmann, WM | 3 |
| Horowski, R | 1 |
| Dannehl, K | 1 |
| Kramer, U | 1 |
| Lurati, K | 1 |
| Somerville, BW | 1 |
| Matevosian, AA | 1 |
| Nattero, G | 2 |
| Agostoni, A | 2 |
| Brandi, G | 2 |
| Cottino, A | 2 |
| Gai, V | 2 |
| Gastaldi, L | 2 |
| Lisino, F | 2 |
| Itil, TM | 2 |
| Akpinar, S | 2 |
| Herrmann, W | 1 |
| Dufresne, JJ | 1 |
| Muggler, J | 1 |
| Probst, C | 1 |
| Lance, JW | 2 |
| Anthony, M | 2 |
| Ripka, O | 1 |
| Paskova, Z | 1 |
| Hodek, B | 1 |
| Miklikova, Z | 1 |
| Whitty, CW | 1 |
| Podvalová, I | 1 |
| Dlabac, A | 1 |
| Somerville, B | 1 |
| Law, FW | 1 |
9 trials available for urea and Migraine Disorders
| Article | Year |
|---|---|
Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks.
Topics: Abdominal Pain; Adolescent; Adult; Aged; Analgesics; Aspirin; Caffeine; Double-Blind Method; Drug Th | 1999 |
Clinical effectiveness of lisuride hydrogen maleate: a double-blind trial versus methysergide.
Topics: Adult; Clinical Trials as Topic; Ergolines; Female; Humans; Male; Maleates; Methysergide; Middle Age | 1977 |
Migraine prophylaxis with Lisuride hydrogen maleate--a double blind study of Lisuride versus placebo.
Topics: Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Ergolines; Humans; Migraine Disorder | 1978 |
[Comparative evaluation of the new antiserotonin preparations, sandomigran and lizenil, in treating patients suffering from migraine].
Topics: Adult; Cerebrovascular Circulation; Chronic Disease; Clinical Trials as Topic; Czechoslovakia; Drug | 1976 |
[Therapeutic possibilities in idiopathic headaches. Analysis of 1000 cases (author's transl)].
Topics: Aspirin; Caffeine; Cinnarizine; Clinical Trials as Topic; Clonidine; Cyproheptadine; Drug Therapy, C | 1975 |
Prediction of psychotropic properties of lisuride hydrogen maleate by quantitative pharmaco-electroencephalogram.
Topics: Adolescent; Adult; Aged; Biological Availability; Child; Child, Preschool; Clinical Trials as Topic; | 1975 |
[Trials with the new preparation cephatac in the attack treatment of migraine (author's transl)].
Topics: Capsules; Complex Mixtures; Drug Combinations; Drug Evaluation; Ergotamines; Humans; Lactones; Migra | 1975 |
[Treatment of 30 patients with HH 232 (author's transl)].
Topics: Analgesics; Clinical Trials as Topic; Complex Mixtures; Drug Evaluation; Ergotamines; Female; Humans | 1974 |
A comparative trial of serotonin antagonists in the management of migraine.
Topics: Clinical Trials as Topic; Cyproheptadine; Ergolines; Humans; Methysergide; Migraine Disorders; Pheno | 1970 |
14 other studies available for urea and Migraine Disorders
| Article | Year |
|---|---|
The involvement of orexin 1 and cannabinoid 1 receptors within the ventrolateral periaqueductal gray matter in the modulation of migraine-induced anxiety and social behavior deficits of rats.
Topics: Animals; Anxiety; Behavior, Animal; Benzoxazoles; Male; Migraine Disorders; Naphthyridines; Orexin R | 2021 |
Activation orexin 1 receptors in the ventrolateral periaqueductal gray matter attenuate nitroglycerin-induced migraine attacks and calcitonin gene related peptide up-regulation in trigeminal nucleus caudalis of rats.
Topics: Animals; Benzoxazoles; Calcitonin Gene-Related Peptide; Male; Microinjections; Migraine Disorders; N | 2020 |
Orexin one receptors within the basolateral amygdala are involved in the modulation of cognitive deficits associated with a migraine-like state in rats.
Topics: Animals; Basolateral Nuclear Complex; Benzoxazoles; Cognitive Dysfunction; Male; Migraine Disorders; | 2021 |
Identification of potent CNS-penetrant thiazolidinones as novel CGRP receptor antagonists.
Topics: Animals; Azepines; Calcitonin Gene-Related Peptide; Dipeptides; Humans; Imidazoles; Inhibitory Conce | 2014 |
The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission.
Topics: Analgesics; Animals; Blood Pressure; Cats; Cerebrovascular Circulation; Disease Models, Animal; Dura | 2009 |
UREA IN THE TREATMENT OF MIGRAINE.
Topics: Biomedical Research; Drug Therapy; Humans; Migraine Disorders; Urea | 1964 |
[Therapeutic possibilities in idiopathic headaches. Analysis of about 1000 cases].
Topics: Cinnarizine; Clonidine; Cyproheptadine; Headache; Histamine; Humans; Methysergide; Migraine Disorder | 1976 |
Discovery of "specific" CNS effects of lisuride hydrogen maleate--an antimigraine compound.
Topics: Brain; Depression, Chemical; Electroencephalography; Ergolines; Humans; Migraine Disorders; Urea | 1975 |
[Effects of a long-term administration on an antiserotonin agent, Lysenyl, in headaches of different origins].
Topics: Adult; Aged; Cerebrovascular Disorders; Ergolines; Erythrocytes; Female; Giant Cell Arteritis; Heada | 1972 |
[Experience with Lysenyl in allergology].
Topics: Adolescent; Adult; Aged; Asthma; Child; Chronic Disease; Conjunctivitis; Eczema; Ergolines; Female; | 1972 |
The aetiology of migraine.
Topics: Cerebrovascular Circulation; Cerebrovascular Disorders; Humans; Migraine Disorders; Urea | 1970 |
Lysenyl, a new antiserotonin agent. Pharmacological and clinical survey.
Topics: Animals; Antihypertensive Agents; Behavior, Animal; Blood Pressure; Dose-Response Relationship, Drug | 1970 |
Thermographic, hormonal, and clinical studies in migraine.
Topics: Body Temperature; Cycloheptanes; Cyproheptadine; Ergolines; Female; Humans; Menstruation; Methysergi | 1970 |
Migraine research.
Topics: Asthenopia; Humans; Migraine Disorders; Refractive Errors; Urea | 1971 |